Amgen's strong Q1 2025 financial results marked a turnaround with substantial net income. Positive performance and ambitious guidance fueled a 1.41% market price increase. Despite risks, diversifying with dividend-paying stocks is advised.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing